- $4.90bn
- $4.31bn
- $1.48bn
Annual balance sheet for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 536 | 608 | 773 | 752 | 588 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 327 | 297 | 333 | 390 | 334 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,062 | 1,130 | 1,486 | 1,415 | 1,929 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 457 | 441 | 318 | 312 | 299 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,024 | 1,964 | 2,136 | 2,056 | 2,487 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 471 | 498 | 520 | 465 | 543 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 912 | 920 | 934 | 591 | 668 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,113 | 1,044 | 1,203 | 1,465 | 1,819 |
| Total Liabilities & Shareholders' Equity | 2,024 | 1,964 | 2,136 | 2,056 | 2,487 |
| Total Common Shares Outstanding |